C02530 -- 3988 -> C00187+C00162

Gomaraschi M, Bonacina F, Norata GD

Lysosomal Acid Lipase: From Cellular Lipid Handler to Immunometabolic Target.

Trends Pharmacol Sci 40:104-115 (2019)
DOI:10.1016/j.tips.2018.12.006

Viaud M, Ivanov S, Vujic N, Duta-Mare M, Aira LE, Barouillet T, Garcia E, Orange F, Dugail I, Hainault I, Stehlik C, Marchetti S, Boyer L, Guinamard R, Foufelle F, Bochem A, Hovingh KG, Thorp EB, Gautier EL, Kratky D, Dasilva-Jardine P, Yvan-Charvet L

Lysosomal Cholesterol Hydrolysis Couples Efferocytosis to Anti-Inflammatory Oxysterol Production.

Circ Res 122:1369-1384 (2018)
DOI:10.1161/CIRCRESAHA.117.312333

Mota AC, Dominguez M, Weigert A, Snodgrass RG, Namgaladze D, Brune B

Lysosome-Dependent LXR and PPARdelta Activation Upon Efferocytosis in Human Macrophages.

Front Immunol 12:637778 (2021)
DOI:10.3389/fimmu.2021.637778

Zhang J, Ding W, Zhao M, Liu J, Xu Y, Wan J, Wang M

Mechanisms of efferocytosis in determining inflammation resolution: Therapeutic potential and the association with cardiovascular disease.

Br J Pharmacol 179:5151-5171 (2022)
DOI:10.1111/bph.15939